Annual CFI
$40.21 M
+$40.62 M+9950.22%
December 31, 2022
Summary
- As of February 10, 2025, ERYP annual cash flow from investing activities is $40.21 million, with the most recent change of +$40.62 million (+9950.22%) on December 31, 2022.
- During the last 3 years, ERYP annual CFI has risen by +$62.42 million (+281.05%).
Performance
ERYP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
December 31, 2022
Summary
- ERYP quarterly cash flow from investing activities is not available.
Performance
ERYP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
December 31, 2022
Summary
- ERYP TTM cash flow from investing activities is not available.
Performance
ERYP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ERYP Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9950.2% | - | - |
| 3 y3 years | +281.1% | - | - |
| 5 y5 years | +2082.4% | - | - |
ERYP Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -101.0% | ||||
| 5 y | 5-year | at high | -155.2% | ||||
| alltime | all time | at high | -155.2% |
ERYTECH Pharma SA Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $40.21 M(<-9900.0%) | - | - |
| Jun 2022 | - | $40.42 M(<-9900.0%) | $40.42 M(<-9900.0%) |
| Dec 2021 | -$408.20 K(-75.8%) | - | - |
| Jun 2021 | - | -$330.20 K(-98.5%) | -$330.20 K(-99.2%) |
| Dec 2020 | -$1.68 M(-92.4%) | - | - |
| Dec 2019 | -$22.21 M(+191.6%) | - | - |
| Sep 2019 | - | -$21.49 M(+8.9%) | -$41.22 M(+78.1%) |
| Jun 2019 | - | -$19.74 M | -$23.15 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$7.62 M(+275.5%) | - | - |
| Sep 2018 | - | -$3.41 M | -$3.41 M |
| Dec 2017 | -$2.03 M(+2.6%) | - | - |
| Dec 2016 | -$1.98 M(+527.1%) | - | - |
| Dec 2015 | -$315.20 K(-43.6%) | - | - |
| Dec 2014 | -$558.50 K(+45.7%) | - | - |
| Dec 2013 | -$383.30 K(+2017.7%) | - | - |
| Dec 2012 | -$18.10 K | - | - |
FAQ
- What is ERYTECH Pharma SA annual cash flow from investing activities?
- What is the all time high annual CFI for ERYTECH Pharma SA?
- What is ERYTECH Pharma SA annual CFI year-on-year change?
- What is the all time high quarterly CFI for ERYTECH Pharma SA?
- What is the all time high TTM CFI for ERYTECH Pharma SA?
What is ERYTECH Pharma SA annual cash flow from investing activities?
The current annual CFI of ERYP is $40.21 M
What is the all time high annual CFI for ERYTECH Pharma SA?
ERYTECH Pharma SA all-time high annual cash flow from investing activities is $40.21 M
What is ERYTECH Pharma SA annual CFI year-on-year change?
Over the past year, ERYP annual cash flow from investing activities has changed by +$40.62 M (+9950.22%)
What is the all time high quarterly CFI for ERYTECH Pharma SA?
ERYTECH Pharma SA all-time high quarterly cash flow from investing activities is $40.42 M
What is the all time high TTM CFI for ERYTECH Pharma SA?
ERYTECH Pharma SA all-time high TTM cash flow from investing activities is $40.42 M